HMBD-011

N/A

Report date: 2024/10/14 15:14:41

Base Information

Drug NameHMBD-011
Drug Alias NameHMBD-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsAnti-Immunoglobulin Heavy Variable 4-34
TargetsImmunoglobulin Heavy Variable 4-34
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHummingbird Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesHummingbird Bioscience
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A